Skip to content

Clinical trials

Completed Phase 1/2 Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 1/2 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20032
20043
20052
20061
20071
20101
20111
20125
20164
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Fred Hutchinson Cancer Center2
Memorial Sloan Kettering Cancer Center2
Valerio Therapeutics2
Vejle Hospital2
Corcept Therapeutics1
Cybrexa Therapeutics1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Garden State Cancer Center at the Center for Molecular Medicine and Immunology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial32
Ovarian Neoplasms21
Fallopian Tube Neoplasms13
Breast Neoplasms11
Burkitt Lymphoma4
Carcinoma, Non-Small-Cell Lung4
Hodgkin Disease4
Leukemia4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.